Fred Ong

Fred Ong currently serves as CFO at Jupiter Endovascular since 2025. Prior to this role, Ong held CFO positions at Sirona Medical from 2020 to 2024 and at Datavant from 2018 to 2019, where Datavant's technology aimed to connect health data while ensuring patient privacy, culminating in a $7 billion merger with Ciox Health. Ong co-founded Alara Systems Inc. and served as CFO from 2014 to 2017, focusing on machine learning technology for mammography. Earlier experience includes CFO and COO roles at U-Systems, successfully sold to GE Healthcare in 2012, and VP Finance positions at R2 Technology, sold to Hologic in 2006, and Mirapoint Inc., sold to Critical Path in 2010. Ong began a career in finance as a controller at ZeitNet Inc. and as a Sr. Audit Associate at PwC. Ong earned a Bachelor of Science in Business Administration from the University of California, Berkeley, Haas School of Business.